Endometrium in PCOS: Implantation and predisposition to endocrine CA

被引:344
作者
Giudice, Linda C. [1 ]
机构
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA
关键词
endometrium; polycystic ovarian syndrome; hyperinsulinemia; steroid receptors; co-activators; androgens; insulin; insulin-like growth factors; implantation; endometrial receptivity; miscarriage; endometrial hyperplasia; endometrial cancer;
D O I
10.1016/j.beem.2006.03.005
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Polycystic ovarian syndrome (PCOS) is a common endocrinopathy characterized by oligo/anovulatiaon and elevated circulating androgens or evidence of hyperandrogenism after all known potential causes have been excluded. In addition, insulin resistance and accompanying hyperinsulinernia commonly occur in women with PCOS. There is increasing evidence that the endocrinologic and metabolic abnormalities in PCOS may have complex effects on the endometrium, contributing to the infertility and endometrial disorders observed in women with this syndrome. Androgen receptors and steroid receptor co-activators are over-expressed in the endometrium of women with PCOS. Also, biomarkers of endometrial receptivity to embryonic implantation-such as alpha(v)beta(3)-integrin and glycodelin-are decreased, and epithelial expression of estrogen receptor alpha (ER alpha) abnormally persists in the window of implantation in endometrium in women with PCOS. In addition to being responsive to the steroid hormones estr-adiol, progesterone, and androgens, the endometrium is also a target for insulin, the receptor for which is cyclically regulated in normo-ovulatory women. In vitro, insulin inhibits the normal process of endometrial stromal differentiation (decidualization). In addition, insulin-like growth factors (IGFs) and their binding proteins are regulated in and act on endometrial cellular constituents, and hyperinsulinernia down-regulates hepatic IGFBP-1, resulting in elevated free IGF-I in the circulation. Thus, elevated estrogen (without the opposing effects of progesterone in the absence of ovulation), hyperinsulinernia, elevated free IGF-I and androgens, and obesity all likely contribute to endometrial dysfunction, infertility, increased miscarriage rate, endometrial hyperplasia, and endometrial cancer common in women with PCOS. The potential mechanisms underlying these disorders, specifically in women with PCOS, are complex and await additional transdisciplinary research for their complete elucidation.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 49 条
[1]
Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome [J].
Apparao, KBC ;
Lovely, LP ;
Gui, YT ;
Lininger, RA ;
Lessey, BA .
BIOLOGY OF REPRODUCTION, 2002, 66 (02) :297-304
[2]
POLYCYSTIC-OVARY-SYNDROME PATIENTS AS OOCYTE DONORS - THE EFFECT OF OVARIAN STIMULATION PROTOCOL ON THE IMPLANTATION RATE OF THE RECIPIENT [J].
ASHKENAZI, J ;
FARHI, J ;
ORVIETO, R ;
HOMBURG, R ;
DEKEL, A ;
FELDBERG, D ;
BENRAFAEL, Z .
FERTILITY AND STERILITY, 1995, 64 (03) :564-567
[3]
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[4]
MISCARRIAGE RATES FOLLOWING INVITRO FERTILIZATION ARE INCREASED IN WOMEN WITH POLYCYSTIC OVARIES AND REDUCED BY PITUITARY DESENSITIZATION WITH BUSERELIN [J].
BALEN, AH ;
TAN, SL ;
MACDOUGALL, J ;
JACOBS, HS .
HUMAN REPRODUCTION, 1993, 8 (06) :959-964
[5]
BALLARD FJ, 1993, GROWTH REGULAT, V3, P40
[6]
Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells [J].
Bermont, L ;
Lamielle, F ;
Lorchel, F ;
Fauconnet, S ;
Esumi, H ;
Weisz, A ;
Adessi, GL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :363-368
[7]
BOLTON AE, 1987, LANCET, V1, P593
[8]
Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome [J].
Cheung, AP .
OBSTETRICS AND GYNECOLOGY, 2001, 98 (02) :325-331
[9]
Natural killer cells in pregnancy and recurrent pregnancy loss: Endocrine and immunologic perspectives [J].
Dosiou, C ;
Giudice, LC .
ENDOCRINE REVIEWS, 2005, 26 (01) :44-62
[10]
Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis [J].
Dunaif, A .
ENDOCRINE REVIEWS, 1997, 18 (06) :774-800